Literature DB >> 36165644

Synbiotic Intervention with Lactobacilli, Bifidobacteria, and Inulin in Healthy Volunteers Increases the Abundance of Bifidobacteria but Does Not Alter Microbial Diversity.

Ingrid Maria Cecilia Rubin1,2, Sarah Mollerup1, Christa Broholm3, Adam Baker3, Mona Katrine Alberthe Holm1, Martin Schou Pedersen1, Mette Pinholt1, Henrik Westh1,4, Andreas Munk Petersen1,2,4.   

Abstract

Synbiotics combine probiotics and prebiotics and are being investigated for potential health benefits. In this single-group-design trial, we analyzed changes in the gut microbiome, stool quality, and gastrointestinal well-being in 15 healthy volunteers after a synbiotic intervention comprising Lacticaseibacillus rhamnosus (LGG), Lactobacillus acidophilus (LA-5), Lacticaseibacillus paracasei subsp. paracasei (L. CASEI 431), and Bifidobacterium animalis subsp. lactis BB-12 and 20 g of chicory-derived inulin powder consumed daily for 4 weeks. Fecal samples were collected at baseline and at completion of the intervention, and all participants completed a fecal diary based on the Bristol Stool Scale and recorded their gastrointestinal well-being. No adverse effects were observed after consumption of the synbiotic product, and stool consistency and frequency remained almost unchanged during the trial. Microbiome analysis of the fecal samples was achieved using shotgun sequencing followed by taxonomic profiling. No changes in alpha and beta diversity were seen after the intervention. Greater relative abundances of Bifidobacteriaceae were observed in 12 subjects, with indigenous bifidobacteria species constituting the main increase. All four probiotic organisms increased in abundance, and L. rhamnosus, B. animalis, and L. acidophilus were differentially abundant, compared to baseline. Comparison of the fecal strains to the B. animalis subsp. lactis BB-12 reference genome and the sequenced symbiotic product revealed only a few single-nucleotide polymorphisms differentiating the probiotic B. animalis subsp. lactis BB-12 from the fecal strains identified, indicating that this probiotic strain was detectable after the intervention. IMPORTANCE The effects of probiotics/synbiotics are seldom investigated in healthy volunteers; therefore, this study is important, especially considering the safety aspects of multiple probiotics together with prebiotic fiber in consumption by humans. The study explores at the potential of a synbiotic intervention with lactobacilli, bifidobacteria, and inulin in healthy volunteers and tracks the ingested probiotic strain B. animalis subsp. lactis.

Entities:  

Keywords:  bifidobacteria; fecal; inulin; lactobacilli; metagenomics; microbiome; prebiotics; probiotics; shotgun; synbiotics

Mesh:

Substances:

Year:  2022        PMID: 36165644      PMCID: PMC9552601          DOI: 10.1128/aem.01087-22

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   5.005


  47 in total

1.  MetaPhlAn2 for enhanced metagenomic taxonomic profiling.

Authors:  Duy Tin Truong; Eric A Franzosa; Timothy L Tickle; Matthias Scholz; George Weingart; Edoardo Pasolli; Adrian Tett; Curtis Huttenhower; Nicola Segata
Journal:  Nat Methods       Date:  2015-10       Impact factor: 28.547

Review 2.  The effects of inulin on gut microbial composition: a systematic review of evidence from human studies.

Authors:  Quentin Le Bastard; Guillaume Chapelet; François Javaudin; Didier Lepelletier; Eric Batard; Emmanuel Montassier
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-11-09       Impact factor: 3.267

Review 3.  Gut microbiota in the pathogenesis of inflammatory bowel disease.

Authors:  Atsushi Nishida; Ryo Inoue; Osamu Inatomi; Shigeki Bamba; Yuji Naito; Akira Andoh
Journal:  Clin J Gastroenterol       Date:  2017-12-29

Review 4.  Introducing inulin-type fructans.

Authors:  Marcel B Roberfroid
Journal:  Br J Nutr       Date:  2005-04       Impact factor: 3.718

5.  Synbiotic Lactobacillus acidophilus NCFM and cellobiose does not affect human gut bacterial diversity but increases abundance of lactobacilli, bifidobacteria and branched-chain fatty acids: a randomized, double-blinded cross-over trial.

Authors:  Gabriella C van Zanten; Lukasz Krych; Henna Röytiö; Sofia Forssten; Sampo J Lahtinen; Waleed Abu Al-Soud; Søren Sørensen; Birte Svensson; Lene Jespersen; Mogens Jakobsen
Journal:  FEMS Microbiol Ecol       Date:  2014-09-05       Impact factor: 4.194

Review 6.  The gut microbiota and inflammatory bowel disease.

Authors:  Katsuyoshi Matsuoka; Takanori Kanai
Journal:  Semin Immunopathol       Date:  2014-11-25       Impact factor: 9.623

Review 7.  Microbiome Datasets Are Compositional: And This Is Not Optional.

Authors:  Gregory B Gloor; Jean M Macklaim; Vera Pawlowsky-Glahn; Juan J Egozcue
Journal:  Front Microbiol       Date:  2017-11-15       Impact factor: 5.640

8.  Unifying the analysis of high-throughput sequencing datasets: characterizing RNA-seq, 16S rRNA gene sequencing and selective growth experiments by compositional data analysis.

Authors:  Andrew D Fernandes; Jennifer Ns Reid; Jean M Macklaim; Thomas A McMurrough; David R Edgell; Gregory B Gloor
Journal:  Microbiome       Date:  2014-05-05       Impact factor: 14.650

9.  EMPeror: a tool for visualizing high-throughput microbial community data.

Authors:  Yoshiki Vázquez-Baeza; Meg Pirrung; Antonio Gonzalez; Rob Knight
Journal:  Gigascience       Date:  2013-11-26       Impact factor: 6.524

10.  Trimmomatic: a flexible trimmer for Illumina sequence data.

Authors:  Anthony M Bolger; Marc Lohse; Bjoern Usadel
Journal:  Bioinformatics       Date:  2014-04-01       Impact factor: 6.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.